[Penile cancer : Diagnosis and treatment].
Peniskarzinom : Diagnose und Therapie.
Genital neoplasms, male
Lymph node excision
Penis
Prognosis
Urologic surgical procedures, male
Journal
Der Urologe. Ausg. A
ISSN: 1433-0563
Titre abrégé: Urologe A
Pays: Germany
ID NLM: 1304110
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
pubmed:
6
2
2020
medline:
7
3
2020
entrez:
6
2
2020
Statut:
ppublish
Résumé
The incidence of penile cancer in central Europe and North America is low, and patients often present at a late stage of the disease. The diagnosis can very often be made by visual examination of the primary tumor. Its morphology, size, and location as well as the inguinal lymph nodes are of clinical interest. The removal of (micro)metastatic lymph nodes is decisive for the prognosis. These cannot be diagnosed clinically or by imaging with sufficient reliability, which makes invasive lymph node staging necessary. Penile cancer can only be cured by surgery in patients with localized cancer and early stage regional lymph node metastasis. The primary tumor, including metastatic lymph nodes, must be completely excised as early as possible. If indicated, organ preservation must be performed with strict adherence of safety margins. Optimal lymph node management is crucial for long-term survival.
Identifiants
pubmed: 32020240
doi: 10.1007/s00120-020-01128-6
pii: 10.1007/s00120-020-01128-6
doi:
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
209-218Références
Virchows Arch. 2011 Feb;458(2):221-9
pubmed: 21085986
Scand J Urol Nephrol Suppl. 2000;(205):189-93
pubmed: 11144896
BJU Int. 2006 Dec;98(6):1225-7
pubmed: 17125480
J Nucl Med. 2005 Sep;46(9):1460-5
pubmed: 16157528
Int Braz J Urol. 2008 Sep-Oct;34(5):587-91; discussion 591-3
pubmed: 18986562
Eur Urol. 2012 Nov;62(5):923-8
pubmed: 22421082
BJU Int. 2018 Oct;122(4):576-582
pubmed: 29604228
Eur Urol. 2007 Jul;52(1):17-9; discussion 20-1
pubmed: 17376585
Acta Oncol. 1988;27(6b):823-4
pubmed: 2466471
Am J Pathol. 2001 Oct;159(4):1211-8
pubmed: 11583947
Int J Surg Pathol. 2004 Apr;12(2):139-46
pubmed: 15173919
J Urol. 1999 Jun;161(6):1823-5
pubmed: 10332445
Eur Urol. 2008 Jul;54(1):161-8
pubmed: 18440124
Eur Urol. 2007 May;51(5):1313-8; discussion 1318-9
pubmed: 17113213
BJU Int. 2005 Nov;96(7):1040-3
pubmed: 16225525
J Clin Oncol. 2011 Aug 1;29(22):e650-2
pubmed: 21632506
J Urol. 2005 Mar;173(3):816-9
pubmed: 15711276
Mod Pathol. 2007 Oct;20(10):1069-77
pubmed: 17690710
BJU Int. 2006 Jun;97(6):1225-8
pubmed: 16686716
J Urol. 2002 Jan;167(1):89-92; discussion 92-3
pubmed: 11743282
Eur Urol. 2010 Jun;57(6):1002-12
pubmed: 20163910
Br J Urol. 1995 Mar;75(3):375-7
pubmed: 7735804
World J Urol. 2009 Apr;27(2):179-87
pubmed: 18636263
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2683-91
pubmed: 18843010
Eur Urol. 2009 Mar;55(3):546-51
pubmed: 18649992
J Urol. 1991 Nov;146(5):1284-7
pubmed: 1719241
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1150-6
pubmed: 19395183
Urologe A. 2009 Dec;48(12):1495-8
pubmed: 19774356
Urol Oncol. 2011 Nov-Dec;29(6):788-93
pubmed: 19945305
Eur Urol. 2009 May;55(5):1075-88
pubmed: 19264390
Eur Urol. 1997;32(1):5-15
pubmed: 9266225
J Clin Oncol. 2010 Aug 20;28(24):3851-7
pubmed: 20625118